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Topoisomerase activities have heen measured in nuclear extracts of concanavalin A-stimulated lymphocytes. 
In parallel with the wave of DNA synthesis, type II topoisomerase activity was considerably increased. After 
72 h treatment, this activity was stimulated approx. 20-fold over the activity in untreated cells. In contrast, 
type I topoisomerase was poorly stimulated after 24 h treatment, and 4-5-fold after 72 h. These findings, 
together with our previous results on regenerating rat liver, suggest amajor role of topoisomerase II in DNA 
replication. 
Mitogenic agent DNA replication 
1. INTRODUCTION 
Circumstantial evidence for the involvement of 
topoisomerases in DNA replication has been 
demonstrated in a variety of experimental systems 
[l-3], especially in prokaryotes and bacterio- 
phages. In these organisms, the concerted use of 
specific inhibitors [4,5] and conditional lethal 
mutants [6] led to the conclusion that gyrase 
(topoisomerase II) was involved in DNA replica- 
tion, in particular in the initiation stage. This con- 
clusion was also supported by studies on an in vitro 
replication system using the Escherichia coli origin 
of replication (ori C) [7]. In this system, the w pro- 
tein (topoisomerase I) was also necessary [3]. One 
hypothesis is that *I and gyrase may regulate DNA 
replication (as well as other genetic processes) by 
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Lymphocyte Topoisomerase 
precisely controlling the level of superhelicity of 
the DNA. 
In eukaryotes, very little is known on the func- 
tion of topoisomerases. Since the discovery of a 
nicking-closing (topoisomerase I) activity in mam- 
malian cells 181, a common idea was that this type 
of enzyme represents the hypothetic swivelase 
necessary to remove the positive supercoils 
generated ahead of the replication fork [8]. 
However, topoisomerase I activity was found 
remarkably constant in a variety of systems, in- 
cluding cultured cells in S phase, virus-infected 
cells or regenerating liver [9,10]. In contrast, we 
have shown that eukaryotic type II topoisomerase, 
a ubiquitous enzyme initially discovered for its 
catenation properties [l l] was considerably in- 
creased in regenerating liver [lo]. Recently, a type 
II topoisomerase activity was reported to be in- 
duced in fibroblasts by the action of epidermal 
growth factor (EGF) [12]. Moreover, it has been 
suggested that the EGF receptor was itself a 
topoisomerase [131. 
’ Here, we describe another experimental system 
in which type II topoisomerase is considerably in- 
creased: cultured guinea pig lymphocytes 
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stimulated by the mitotic agent Con A. This 
system is useful for studying the sequence of events 
during the transition of a cell from a resting to an 
active growth state. 
2. EXPERIMENTAL 
2.1. Cell cultures and thymidine incorporation 
The preparation of guinea pig lymph node cell 
suspensions and cell cultures was performed as 
previously described [14]. The cells were cultured 
at a concentration of l-2 x lo6 cells/ml in tissue 
culture flasks (Falcon) in a volume of 12 ml per 
flask. Cultures were incubated at 37”C, in a 
humidified atmosphere containing 5% CO2 in air. 
The culture medium was RPM1 1640 [15] sup- 
plemented with 100 U/ml penicillin and 5% guinea 
pig serum. Cultures were stimulated by the addi- 
tion of 7.5 pg/ml of Con A (Miles-Yeda). 
[3H]thymidine (CEA, Saclay) incorporation was 
measured with 24-h pulses as in [14]. 
2.2. Preparation of nuclear extracts 
Cultured lymphocytes (10’ cells) were centrifug- 
ed at 650 x g for 10 min, washed in 10 ml of 
50 mM Tris-HCl, pH 7.5, 25 mM KCl, 2 mM 
CaClz, 3 mM MgClz (TKCM buffer) containing 
0.25 M sucrose and 1 mM PMSF (from Sigma) 
and resuspended in 1 ml of the same buffer. The 
cells were disrupted in a Potter homogenizer at 
O”C, and centrifuged at 2000 x g for 10 min. The 
nuclear pellet was suspended in 1 ml of TKCM 
buffer containing 0.25 M sucrose, layered over a 
0.4 ml cushion of TKCM buffer containing 0.6 M 
sucrose, and centrifuged at 2080 x g for 10 min. 
The nuclei were then washed in TKCM containing 
0.25 M sucrose and 0.5Vo T&on X-100. At this 
stage, aliquots of nuclei suspension, dispersed in 
Triton X-100~TKCM buffer, were easily counted 
in a Malassez chamber under the microscope [lo]. 
The nuclei were collected by centrifugation at 
2000 x g for 10 min, washed twice with 
TKM-0.25 M sucrose buffer (identical to TKCM, 
but containing 5 mM MgClz instead of 3 mM 
MgClz, and lacking CaClz) and finally resuspended 
in 0.3 ml of TKM. 
The nuclear extracts were prepared as previously 
described [lo] by lysis at high ionic strength 
followed by polyethylene glycol (PEG 6000) 
precipitation of nucleic acids. The final supema- 
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tant was referred to as Fraction II and utilized to 
measure topoisomerase activities. 
2.3. Preparation of the DNA substrates 
Kinetoplast DNA (k.DNA) was purified from 
sarkosyl extracts of Trypanosoma cruzi cultures 
kindly provided by A. Berneman and H. Eisen 
(Departement d’Immunologie, Institut Pasteur). 
After extraction of proteins with phenol, the 
k.DNA was purified by cesium chloride-ethidium 
bromide density centrifugation [ 161. 
Supercoiled plasmid pBR 322 was prepared 
from E. coli strain HB 101 as in [lo]. 
2.4. Topoisomerase assays and quantitation of 
activities 
Detection of topoisomerase activities in lym- 
phocytes has been performed on serial dilutions of 
the nuclear extracts (fraction II), as described in 
the case of regenerating liver [lo]. Dilution of the 
extract has several advantages: as shown in the up- 
per part of fig.1, reiaxation of the DNA was 
severely reduced with pure fraction II from lym- 
phocytes (lane 2), but was already apparent with 
dilutions l/2 (lane 3), l/4 (lane 4) or with more 
dilute fractions. This phenomenon, also found in 
rat liver [lo] and in mouse L cells [17] was first 
described in the case of calf thymus and Hela cells 
[ 181. Dilutions ranging from l/8 to l/200 were 
used here, so that the effect of ‘crude fraction’ was 
abolished. Moreover, the possible interference 
with nuclease activities (although these are not pro- 
minent in our lymphocyte extracts) was also 
minimized by dilution. As shown in an agarose gel 
containing chloroquine (fig. 1, lower part), relaxa- 
tion of the DNA, even with the slightly diluted 
fraction II (l/4 or l/2), gave covalently closed 
DNA without apparent increase in form II. 
Both topoisomerases I and II were present in the 
same extracts. Separate determination of each type 
of enzyme was performed by using specific assays, 
as previously described in the case of regenerating 
rat liver nuclei [lo]. 
Topoisomerase I was measured by the relaxation 
of supercoiled DNA (pBR 322) in the absence of 
ATP and magnesium ions. Topoisomerase II was 
measured by the decatenation of the natural net- 
works of kinetoplast DNA (k.DNA) in the 
presence of ATP and magnesium ions. In both 
cases, serial dilutions of the extracts were used and 
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Fig. 1. Relaxation of pBR 322 DNA by various dilutions 
of fraction II from lymphocytes. The DNA (0.4 pg) was 
incubated with 2 yl of fraction II in the presence ofATP 
and magnesium, as in [lo]. In these conditions, both 
topoisomerase I and II are active [lo]. After incubation, 
each sample was separated intwo halves and analysed in 
two agarose gels. Upper: gel without chloroquine. 
Lower: gel run in the presence of 3 &ml chloroquine. 
Lane 1, pBR 322 control; lanes 2-4, dilutions l/l, l/2, 
l/4 of fraction II. 
the products of incubations were analyzed by elec- 
trophoretic migration in 1% agarose gels, essen- 
tially as previously described [IO]. After migration 
and staining with ethidium bromide, photographs 
of the gels were taken under short-wave (254 nm) 
UV light. Densitometric profiles of the negatives 
were made using a Vernon densitometer and peak 
areas of the supercoiled and relaxed DNA (in the 
case of relaxation) and of the free minicircles (in 
the case of decatenation) were directly integrated. 
In each case, peak areas obtained with the various 
dilutions of the extracts were compared to stan- 
dards of fully supercoiled and fully relaxed DNA 
on one hand, and of fully decatenated k.DNA 
(100% minicircles) on the other. 
One unit of topoisomerase I is defined as the 
amount of enzyme necessary to relax 50% of the 
0.4 ,ug input supercoiled DNA in 30 min at 37°C. 
One unit of topoisomerase II is defined as the 
amount of enzyme necessary to decatenate 50% of 
the 0.3 /cg input k.DNA in 30 min at 30°C. 
In some experiments, the DNA was analyzed in 
agarose gels containing 3 Fg/ml chloroquine, a 
drug which changes the torsion of the DNA, allow- 
ing a clear separation of nicked (form II) DNA 
from covalently closed forms. 
3. RESULTS AND DISCUSSION 
Fig.2 illustrates a gel analysis of topoisomerase 
II activities in Con A-treated lymphocytes: 
decatenation of kinetoplast DNA gave rise to 
1.48 kbp minicircles appearing as a rapidly 
migrating band in agarose gels (lanes 1,8). 
Topoisomerase II was present at low levels in un- 
treated lymphocytes (lanes 2-4) and considerably 
stimulated in lymphocytes cultured for 72 h with 
Con A (lanes 5-7). 
The quantitative aspects of the present study are 
represented in table 1 and fig.3. The number of en- 
zyme units per 10’ nuclei (table 1) and the stimula- 
tion ratio (fig.3) are expressed as a function of time 
Fig.2. Decatenation (topoisomerase II) activities in 
lymphocyte nuclei after 72 h of culture. Rinetoplast 
DNA (0.3 cg) was incubated in the standard reaction 
mixture with serial dilutions of the nuclear extracts 
(fraction II) for 30 min at 3O”C, and analysed in an 
agarose gel. Lane 1 and 8: decatenated k.DNA control. 
Lanes 2-4, activities in untreated lymphocytes with 
dilutions l/8, l/4, and l/2. Lanes 5-7, activities in 
Con A-treated lymphocytes with dilutions l/48, l/32, 
l/16. 
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Table 1 
Topoisomerase activities in lymphocytes after various 
stimulation times 
Enzyme 
Time of 
Topoisomerase I Topoisomerase II 
( lo3 units/ (units/ 
lo8 nuclei) lo8 nuclei) 
culture (h) 24 48 72 24 48 72 
Treated by 
Con A 5.7 12.8 24.5 760 1340 3900 
Untreated 5.3 4.8 4.5 217 245 224 
Enzymatic activities, assayed as described in section 2, 
are expressed in 10’ units/lo8 nuclei (topoisomerase I) Ior 
in units/lo8 nuclei (topoisomerase II). Each value is an 
average of 3-5 independent preparations of 
lymphocytes 
of culture. Treatment of lymphocytes with Con A 
resulted in a wave of DNA synthesis as shown by 
[3H]thymidine incorporation (fig.3A) up to 3 days 
of culture. 
Type II topoisomerase activity exhibited a con- 
siderable increase during this period (fig.3B). This 
increase closely paralleled the stimulation of DNA 
polymerase activity previously described in this ex- 
perimental system [191 or in closely related systems 
[20,21]. After 72 h of treatment, the stimulation 
ratio was respectively about 13 and 18 for DNA 
polymerase [19] and topoisomerase II. In contrast, 
topoisomerase I activity was poorly stimulated 
after 24 h of treatment and 4-5-fold after 72 h 
(fig.3B and table 1). In untreated control lym- 
phocytes, thymidine incorporation (fig.3A) as well 
as topoisomerases I and II activities (table 1) did 
not change appreciably with the time of culture, as 
also reported in the case of DNA polymerase. 
The experiments reported here indicate in the 
first place that both tspoimmerases are present in 
unstimulated lymphocytes, though at a low level in 
the case of type II emqrme. These results are consis- 
tent with the situation found in other resting cells 
[lo]. Upon stimulation of the cells, the increase of 
type II topoisomerase is precisely parallel to the 
rise of DNA replication rate and of DNA 
polymerase activity [19,20], as we have recently 
reported in regenerating liver [lo]. These findings 
suggest that ype II topoisomerase, as DNA 
poiymerase, plays a major role in DNA replication 
or in reiated processes such as chromatin 
decondensatiog/conn in mammalian cells. 
Recent studies on topoisomerase II thermosen- 
sitive mutants in yeast 1221 indicate that the en- 
zyme is probabIy necessary for the segregation of 
chromosomes at the termination of DNA replica- 
tion. Slrnilar results were reported by authors in 
[23] in E. cd gyrB ts mutants, where daughter 
nucleoids remained catenated at the non- 
permissive temperature. Studies of chromatin 
assembly in Xenopus oocytes suggest he possible 
involvement of type II topoisomerase in this 
process. 
We also demonstrate that type I topoisomerase 
stimulation ratio (ConA treated/untreated) % TdR incorporated 
tcpm x m-4 
Fig.3. Stimulation of topoisomerases in Con A-treated lymphocytes. (A) [3H]Tbymidine incorporation into 
lymphocytes after various culture times: (M), lymphocytes treated with Con A; (o---O), untreated control. (B) 
The ratio of topoisomerases activities plotted against the culture time: (M ), topoisomerase I; (o---O), 
topoisomerase II. The vertical bars represent the extreme variations observed in various lymphocyte preparations. 
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is increased in stimulated lymphocytes, though at 
a moderate level. This result is in agreement with 
[24] in the case of synchronized lymphocytes, but 
contrasts with data reported [9, lo] in several other 
biological systems, including cell cultures, virus- 
infected cells and regenerating liver where 
topoisomerase I activity remains constant. This 
situation is perhaps restrained to lymphocytes 
where repair and recombination capacity is high 
Lm and may correlate with increase in 
topoisomerase I activity, if, as has been suggested 
[25], this enzyme is involved in recombination. 
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